- 全部删除
- 您的购物车当前为空
Valecobulin hydrochloride (CKD-516 hydrochloride) 是 S516 的缬氨酸前体药和血管阻断剂。Valecobulin hydrochloride (CKD-516 hydrochloride) 对β-微管蛋白聚合有强效的抑制作用,对小鼠和人类的实体肿瘤具有显著的抗肿瘤活性。
Valecobulin hydrochloride (CKD-516 hydrochloride) 是 S516 的缬氨酸前体药和血管阻断剂。Valecobulin hydrochloride (CKD-516 hydrochloride) 对β-微管蛋白聚合有强效的抑制作用,对小鼠和人类的实体肿瘤具有显著的抗肿瘤活性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 598 | In stock | |
5 mg | ¥ 1,730 | In stock | |
10 mg | ¥ 2,560 | In stock | |
25 mg | ¥ 4,090 | In stock | |
50 mg | ¥ 5,560 | In stock | |
100 mg | ¥ 7,380 | In stock | |
200 mg | ¥ 9,950 | In stock | |
1 mL x 10 mM (in DMSO) | ¥ 2,190 | In stock |
Valecobulin hydrochloride 相关产品
产品描述 | Valecobulin hydrochloride (CKD-516 hydrochloride) is the valine prodrug and vasoblocker of S516. Valecobulin hydrochloride (CKD-516 hydrochloride) has a potent inhibitory effect on β-tubulin polymerization and has significant anti-tumor activity against solid tumors in mice and humans. |
体内活性 | 方法:用Valecobulin hydrochloride (CKD-516 hydrochloride)(5 mg/kg 和10 mg/kg,腹腔注射,Q4D 4)治疗携带人结肠 HCT116 和人结肠过表达 P-gp 转运体 HCT15 的裸鼠。 结果:Valecobulin hydrochloride (CKD-516 hydrochloride)对HCT116裸鼠体内的IR 分别为 36%和65%,肿瘤生长以剂量依赖性方式得到显著抑制;Valecobulin hydrochloride (CKD-516 hydrochloride)还表现出对 MDR 阳性细胞系 (HCT15) 的强效抗肿瘤活性,IR 分别为12%和5 %。[2] |
别名 | CKD-516 hydrochloride |
分子量 | 573.06 |
分子式 | C26H29ClN6O5S |
CAS No. | 1240321-53-2 |
Smiles | Cl.COc1cc(cc(OC)c1OC)C(=O)c1ccc(cc1-n1cncn1)-c1csc(NC(=O)[C@@H](N)C(C)C)n1 |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 125 mg/mL (218.13 mM), Sonication is recommended. H2O: 50 mg/mL (87.25 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容